Medpage Today on MSN2d
Genetic Risk Predictor Might Boost Detection of Undiagnosed COPD
If a threshold of 10% risk of COPD was used to make spirometry referrals, the addition of the polygenic risk score correctly ...
News Medical on MSN2d
COPD is the sixth leading cause of death in the US
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of ...
Too Old to Operate16h
Machine Learning-Based Speech Analysis to Predict COPD Status
The following is a summary of “Assessing the Clinical and Functional Status of COPD Patients Using Speech Analysis During and ...
Island4h
Medical expert: 10% of Sri Lankans over 40 suffer from COPD
About 10% of Sri Lankans over the age of 40 are affected by Chronic Obstructive Pulmonary Disease (COPD), a condition often linked to smoking, prolonged exposure to air pollution, or untreated asthma, ...
HealthDay on MSN4h
Injurious Falls Common in Last Years of Life With COPD
Injurious falls are common among people with chronic obstructive pulmonary disease (COPD) in the two years before death, with some medications tied to higher fall risk, according to a study published ...
Amarillo Globe-News on MSN3d
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patients
After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
COPD market to expand with AstraZeneca’s focus on biologics and strong portfolio growth
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
pulmonologyadvisor1d
In COPD Treatment, Tezepelumab Not Linked to Reduced Exacerbations
Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.
Rolling Out10d
Why COPD affects women differently
The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...
EurekAlert!3d
COPD is the sixth leading cause of death in the United States
Chronic lower respiratory diseases, including chronic obstructive pulmonary disease (COPD), are the sixth leading cause of death in the United States, according to the U.S. Centers for Disease Control ...
Rolling Out6d
Conquering COPD through movement and resilience
Learn how personalized exercise routines can transform your COPD journey, enhance resilience, and improve your quality of ...
The Financial Express4d
AstraZeneca’s Fasenra set to revolutionise COPD treatment as Phase III data builds anticipation
AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...